Rubicon Research

Not Rated
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE506V01022
  • NSEID: RUBICON
  • BSEID: 544578
INR
639.80
15.8 (2.53%)
BSENSE

Dec 05

BSE+NSE Vol: 4.51 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Rubicon Research Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
Profit Before Tax
102.00
-11.00
-66.00
63.00
74.00
Adjustment
71.00
46.00
27.00
36.00
28.00
Changes In working Capital
-135.00
-108.00
-15.00
-4.00
-70.00
Cash Flow after changes in Working Capital
39.00
-72.00
-54.00
95.00
32.00
Cash Flow from Operating Activities
21.00
-74.00
-62.00
61.00
5.00
Cash Flow from Investing Activities
-68.00
-32.00
-45.00
-46.00
-84.00
Cash Flow from Financing Activities
43.00
122.00
63.00
51.00
80.00
Net Cash Inflow / Outflow
-3.00
15.00
-45.00
67.00
1.00
Opening Cash & Cash Equivalents
54.00
38.00
84.00
10.00
9.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
50.00
54.00
38.00
77.00
10.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Rubicon Research
Markets Mojo
Figures in Cr
standaloned Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
102.86
246.8
-144.00
-58.32%
Adjustment
71.31
0.5
71.00
14162.00%
Changes In working Capital
-135.08
316.1
-451.00
-142.73%
Cash Flow after changes in Working Capital
39.08
563.4
-524.00
-93.06%
Cash Flow from Operating Activities
21.01
439
-418.00
-95.21%
Cash Flow from Investing Activities
-68.38
1.9
-69.00
-3698.95%
Cash Flow from Financing Activities
43.55
-115.6
158.00
137.67%
Net Cash Inflow / Outflow
-3.82
325.3
-328.00
-101.17%
Opening Cash & Cash Equivalents
54.43
1.6
53.00
3301.87%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
50.61
326.9
-276.00
-84.52%
Cash Flow - Snapshot (Consolidated) - Mar'24
stock-summary

YoY Growth in year ended Mar 2024 is 128.11% vs -19.35% in Mar 2023

Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
21.01
-74.75
128.11%